NCT01955330

Brief Summary

OBJECTIVES: The objectives of the year study are two-fold:

  1. 1.To determine the 5-7 year patency rate (rate of open bypass grafts) of the LITA graft and stent of patients who have already had robotically-assisted Hybrid CABG surgery using CTA and MPS-MIBI.
  2. 2.To determine patient quality of life at 5-7 years after robotically-assisted Hybrid CABG surgery

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

September 27, 2013

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 7, 2013

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
Last Updated

November 6, 2018

Status Verified

November 1, 2018

Enrollment Period

4 years

First QC Date

September 27, 2013

Last Update Submit

November 2, 2018

Conditions

Coronary Artery Disease

Keywords

CABG, Hybrid, Robotic surgery

Outcome Measures

Primary Outcomes (1)

  • Graft patency

    To assess the graft patency of the LITA to LAD performed by the robot and the patency of the Stent.

    5-7 years post Hybrid surgery

Study Arms (1)

Hybrid robotic cabg patients

Postoperative (5-7 years)Hybrid CABG robotically assisted surgical revascularization patients

Procedure: Robotic Hybrid coronary artery revascularization

Interventions

Robotic Hybrid coronary artery revascularizationPROCEDURE

Lita to LAD performed by robot, Hybrid stent to other diseased coronary artery

Also known as: Robotic Hybrid CABG
Hybrid robotic cabg patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients that have previously had Hybrid robotic coronary artery revascularization performed approximately 5-7 years ago at the London Health Sciences Centre, University Hospital by Dr. Kiaii.

You may qualify if:

  • \- Patients that have previously had Hybrid robotic coronary artery revascularization performed approximately 5-7 years ago at the London Health Sciences Centre, University Hospital by Dr. Kiaii.

You may not qualify if:

  • \- Patients not described above

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

London Health Sciences Centre, University & Victoria Hospitals

London, Ontario, N6A 5A5, Canada

Location

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 27, 2013

First Posted

October 7, 2013

Study Start

September 1, 2013

Primary Completion

September 1, 2017

Study Completion

September 1, 2018

Last Updated

November 6, 2018

Record last verified: 2018-11

Locations

CA(1)